"I am in pain!"-a case report of illicit use of transdermal fentanyl patches
- PMID: 22295268
- PMCID: PMC3267509
- DOI: 10.4088/PCC.11l01196
"I am in pain!"-a case report of illicit use of transdermal fentanyl patches
Similar articles
-
A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.Pain Med. 2013 Jan;14(1):75-83. doi: 10.1111/pme.12011. Pain Med. 2013. PMID: 23320402 Clinical Trial.
-
A Fatal Case of Poisoning with Fentanyl Transdermal Patches in Japan.J Forensic Sci. 2019 Nov;64(6):1936-1942. doi: 10.1111/1556-4029.14127. Epub 2019 Jul 24. J Forensic Sci. 2019. PMID: 31340064
-
Fatal misuse of transdermal fentanyl patches.Forensic Sci Int. 2019 Sep;302:109858. doi: 10.1016/j.forsciint.2019.06.016. Epub 2019 Jun 19. Forensic Sci Int. 2019. PMID: 31279508
-
Clinical experience with transdermal fentanyl for the treatment of cancer pain in Germany.Keio J Med. 2004 Mar;53(1):23-9. doi: 10.2302/kjm.53.23. Keio J Med. 2004. PMID: 15096725 Review.
-
Transdermal fentanyl patches in small animals.J Am Anim Hosp Assoc. 2004 Nov-Dec;40(6):468-78. doi: 10.5326/0400468. J Am Anim Hosp Assoc. 2004. PMID: 15533967 Review.
References
-
- Moskovitz M.A. Advances in understanding chronic pain: mechanisms of pain modulation and relationship to treatment. Neurology. 2002;59(5 suppl. 2):S1.
-
- Stewart W.F., Ricci J.A., Chee E., et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443–2454. - PubMed
-
- Stanley T.H. The history and development of the fentanyl series. J Pain Symptom Manage. 1992;7(suppl 3):S3–S7. - PubMed
-
- Titusville, NJ: Janssen Pharmaceutica; 1994. Duragesic package insert.
-
- Marquardt K.A., Tharratt R.S., Musallam N.A. Fentanyl remaining in a transdermal system following three days of continuous use. Ann Pharmacother. 1995;29(10):969–971. PubMed. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources